1
|
El Hejjioui B, Lamrabet S, Amrani Joutei S, Senhaji N, Bouhafa T, Malhouf MA, Bennis S, Bouguenouch L. New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer. Diagnostics (Basel) 2023; 13:diagnostics13111949. [PMID: 37296801 DOI: 10.3390/diagnostics13111949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Revised: 03/22/2023] [Accepted: 03/24/2023] [Indexed: 06/12/2023] Open
Abstract
Triple-negative breast cancer (TNBC) is a specific subtype of breast cancer lacking hormone receptor expression and HER2 gene amplification. TNBC represents a heterogeneous subtype of breast cancer, characterized by poor prognosis, high invasiveness, high metastatic potential, and a tendency to relapse. In this review, the specific molecular subtypes and pathological aspects of triple-negative breast cancer are illustrated, with particular attention to the biomarker characteristics of TNBC, namely: regulators of cell proliferation and migration and angiogenesis, apoptosis-regulating proteins, regulators of DNA damage response, immune checkpoints, and epigenetic modifications. This paper also focuses on omics approaches to exploring TNBC, such as genomics to identify cancer-specific mutations, epigenomics to identify altered epigenetic landscapes in cancer cells, and transcriptomics to explore differential mRNA and protein expression. Moreover, updated neoadjuvant treatments for TNBC are also mentioned, underlining the role of immunotherapy and novel and targeted agents in the treatment of TNBC.
Collapse
Affiliation(s)
- Brahim El Hejjioui
- Biomedical and Translational Research Laboratory, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez 30050, Morocco
- Department of Medical Genetics and Oncogenetics, HASSAN II University Hospital, Fez 30050, Morocco
| | - Salma Lamrabet
- Biomedical and Translational Research Laboratory, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez 30050, Morocco
| | - Sarah Amrani Joutei
- Department of Radiotherapy, HASSAN II University Hospital, Fez 30050, Morocco
| | - Nadia Senhaji
- Faculty of Sciences, Moulay Ismail University, Meknès 50000, Morocco
| | - Touria Bouhafa
- Department of Radiotherapy, HASSAN II University Hospital, Fez 30050, Morocco
| | | | - Sanae Bennis
- Biomedical and Translational Research Laboratory, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez 30050, Morocco
| | - Laila Bouguenouch
- Department of Medical Genetics and Oncogenetics, HASSAN II University Hospital, Fez 30050, Morocco
| |
Collapse
|
2
|
Khalfi S, Ayachi ZE, Sadiki EM, Slassi N, Hassani W, Farhane FZ, Alami Z, Bouhafa T. Cutaneous squamous cell carcinomas of the nose in a child treated with external radiation therapy: a case report. Ecancermedicalscience 2023; 17:1540. [PMID: 37138958 PMCID: PMC10151074 DOI: 10.3332/ecancer.2023.1540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Indexed: 05/05/2023] Open
Abstract
Cutaneous squamous cell carcinomas are very rare in children. The recommended treatment for localized cancers is surgery with sufficient margins which can sometimes be mutilating especially for facial localizations. We report a rare case of facial skin carcinoma in a 13-year-old girl measuring 3 cm in diameter infiltrating the tip of the nose. The treatment was an exclusive external radiation therapy with a dose of 70 Gy in 35 fractions in standard fractionation. The technique used was intensity-modulated conformational radiotherapy. It was proposed as an alternative to surgery which could be mutilating. A complete tumour response was obtained with a good aesthetic result and without major toxicity.
Collapse
Affiliation(s)
- Samia Khalfi
- Department of Radiation Therapy, Oncology Hospital, HASSAN II University Hospital, Fès 30000, Morocco
| | - Zineb El Ayachi
- Department of Radiation Therapy, Oncology Hospital, HASSAN II University Hospital, Fès 30000, Morocco
| | - El Mehdi Sadiki
- Department of Medical Phisic, HASSAN II University Hospital, Fès 30000, Morocco
| | - Noureddine Slassi
- Department of Medical Phisic, HASSAN II University Hospital, Fès 30000, Morocco
| | - Wissal Hassani
- Department of Radiation Therapy, Oncology Hospital, HASSAN II University Hospital, Fès 30000, Morocco
| | - Fatima Zahra Farhane
- Department of Radiation Therapy, Oncology Hospital, HASSAN II University Hospital, Fès 30000, Morocco
| | - Zenab Alami
- Department of Radiation Therapy, Oncology Hospital, HASSAN II University Hospital, Fès 30000, Morocco
| | - Touria Bouhafa
- Department of Radiation Therapy, Oncology Hospital, HASSAN II University Hospital, Fès 30000, Morocco
| |
Collapse
|
3
|
Michalet M, Bettaïeb O, Khalfi S, Ghorbel A, Valdenaire S, Debuire P, Aillères N, Draghici R, De Méric De Bellefon M, Charissoux M, Boisselier P, Demontoy S, Marguerit A, Cabaillé M, Cantaloube M, Keskes A, Bouhafa T, Farcy-Jacquet MP, Fenoglietto P, Azria D, Riou O. Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results. J Clin Med 2022; 12:jcm12010291. [PMID: 36615093 PMCID: PMC9821305 DOI: 10.3390/jcm12010291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2022] [Revised: 12/27/2022] [Accepted: 12/28/2022] [Indexed: 12/31/2022] Open
Abstract
Stereotactic MR-guided Radiotherapy (MRgRT) is an interesting treatment option for adrenal gland metastases (AGM). We reviewed data from 12 consecutive patients treated with MRgRT for an AGM in our center between 14 November 2019 and 17 August 2021. Endpoints were tolerance assessment, the impact of adaptive treatment on target volume coverage and organs at risk (OAR) sparing, local control (LC), and overall survival (OS). The majority of patients were oligometastatic (58.3%), with 6 right AGM, 5 left AGM and 1 left and right AGM. The prescribed dose was 35 to 50 Gy in 3 to 5 fractions. The median PTV V95% on the initial plan was 95.74%. The median V95% of the PTVoptimized (PTVopt) on the initial plan was 95.26%. Thirty-eight (69%) fractions were adapted. The PTV coverage was significantly improved for adapted plans compared to predicted plans (median PTV V95% increased from 89.85% to 91.17%, p = 0.0478). The plan adaptation also significantly reduced Dmax for the stomach and small intestine. The treatment was well tolerated with no grade > 2 toxicities. With a median follow-up of 15.5 months, the 1−year LC and OS rate were 100% and 91.7%. Six patients (50%) presented a metastatic progression, and one patient (8.3%) died of metastatic evolution during the follow-up. Adaptation of the treatment plan improved the overall dosimetric quality of MRI-guided radiotherapy. A longer follow-up is required to assess late toxicities and clinical results.
Collapse
Affiliation(s)
- Morgan Michalet
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
- Correspondence:
| | - Ons Bettaïeb
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Samia Khalfi
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Asma Ghorbel
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Simon Valdenaire
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Pierre Debuire
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Norbert Aillères
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Roxana Draghici
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Mailys De Méric De Bellefon
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Marie Charissoux
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Pierre Boisselier
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Sylvain Demontoy
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Alexis Marguerit
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Morgane Cabaillé
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Marie Cantaloube
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Aïcha Keskes
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Touria Bouhafa
- CHU Hassan II, Radiotherapy and Brachyterapy, 30050 Fez, Morocco
| | - Marie-Pierre Farcy-Jacquet
- Institut de Cancérologie du Gard, University Federation of Radiation Oncology of Mediterranean Occitanie, CHU Carémeau, 30900 Nîmes, France
| | - Pascal Fenoglietto
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - David Azria
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| | - Olivier Riou
- Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France
| |
Collapse
|
4
|
Benhaddouch Y, Khalfi S, Benmaamar S, Marzouki C, Fares NEH, Sbai M, Soussy K, Assenhaji B, Filali H, Aghlallou Y, Bout A, Aarab C, Aalouane R, Farhane F, Alami Z, Bouhafa T. Burnout among physicians and caregivers in oncology: the Moroccan experience. Ecancermedicalscience 2022; 16:1473. [PMID: 36819816 PMCID: PMC9934873 DOI: 10.3332/ecancer.2022.1473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Indexed: 11/18/2022] Open
Abstract
Purpose Caregivers in radiation oncology are exposed to a high risk of burnout which sometimes causes serious consequences for their health, which can in turn affect patient care. In this study, we investigated the prevalence of burnout and its psychological impact on health professionals and determined the factors that predispose to the risk of burnout. Methods and materials A cross-sectional survey was conducted with descriptive and analytical purposes among the different teams within the oncology and radiotherapy departments in different hospitals (CHU and regional hospitals) in Morocco, through an online self-questionnaire composed of sociodemographic data, professional data, working conditions, an assessment of interfering factors, the Maslach Burnout Inventory (MBI), the Generalised Anxiety Disorder-7 (GAD-7) scale and the Patient Health Questionnaire-9 (PHQ-9) scale. Results One hundred and eighteen caregivers participated in this evaluation. 62.7% were physicians, 75.4% worked in university hospitals and 53.4% were in radiotherapy departments. Analysis of the three dimensions of the Maslach Burnout Inventory - Human Services Survey (MBI-HSS) score found high scores in the dimensions of emotional exhaustion (81.4%) and depersonalisation (79.7%), and low scores in decreased personal accomplishment (46.6%). The evaluation of the impacts of burnout in the latter found a mean of the Patient Health Questionnaire-9 (PHQ-9) at 12.45 + 7.84 and the mean of the GAD-7 at 9.73 + 5.98. Conclusion Our results are in line with those found in the literature, hence the need for screening and active prevention of burnout among radiation oncology caregivers.
Collapse
Affiliation(s)
| | - Samia Khalfi
- Department of Radiotherapy and Brachytherapy, CHU Hassan II of Fez, Fez, Morocco
| | - Soumaya Benmaamar
- Department of Epidemiology, Faculty of Medicine and Pharmacy of Fez, Fez, Morocco
| | - Chaymae Marzouki
- Department of Psychiatry-Addictology, CHU Hassan II of Fez, Fez, Morocco
| | | | - Mohamed Sbai
- Department of Psychiatry-Addictology, CHU Hassan II of Fez, Fez, Morocco
| | - Kaoutar Soussy
- Department of Radiotherapy and Brachytherapy, CHU Hassan II of Fez, Fez, Morocco
| | - Bouthaina Assenhaji
- Department of Radiotherapy and Brachytherapy, CHU Hassan II of Fez, Fez, Morocco
| | - Hajar Filali
- Department of Radiotherapy and Brachytherapy, CHU Hassan II of Fez, Fez, Morocco
| | | | - Amine Bout
- Department of Psychiatry-Addictology, CHU Hassan II of Fez, Fez, Morocco
| | - Chadia Aarab
- Department of Psychiatry-Addictology, CHU Hassan II of Fez, Fez, Morocco
| | - Rachid Aalouane
- Department of Psychiatry-Addictology, CHU Hassan II of Fez, Fez, Morocco
| | - Fatimazahra Farhane
- Department of Radiotherapy and Brachytherapy, CHU Hassan II of Fez, Fez, Morocco
| | - Zenab Alami
- Department of Radiotherapy and Brachytherapy, CHU Hassan II of Fez, Fez, Morocco
| | - Touria Bouhafa
- Department of Radiotherapy and Brachytherapy, CHU Hassan II of Fez, Fez, Morocco
| |
Collapse
|
5
|
Aassouani F, El Bouardi N, Charifi Y, Maadin K, Bouziane A, Haloua M, Lamrani MYA, Arifi S, Bouhafa T, Boubbou M, Maaroufi M, Alami B. A rare case of sphenoid giant cell tumor: Case report & review of imaging features post short-term denosumab treatment. Radiol Case Rep 2022; 17:3830-3834. [PMID: 35982722 PMCID: PMC9379972 DOI: 10.1016/j.radcr.2022.07.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2022] [Revised: 07/06/2022] [Accepted: 07/08/2022] [Indexed: 11/17/2022] Open
Abstract
Background: Giant cell tumors (GCTs) are locally aggressive but rarely malignant bone neoplasms that uncommonly involve the skull. In this report, we describe a tumor of the sphenoid sinus. Case presentation: A 51-year-old female was presented with headache, and bilateral decreased visual acuity, CT scan, and brain MRI revealed an infra-sellar enhancing tumor expanding to the sellar and supra-sellar region which proved to be a GCT. the patient had received 03 months of preoperative denosumab-based treatment and imaging follow-up showed regression in size and morphology modifications of tumor tissue. Conclusion: This is one of few reports to describe the appearance of sphenoid bone GCT, and the first report to highlight the effects of short-term denosumab treatment in GCTb in such a location.
Collapse
|
6
|
Bennis A, Alami Z, AChraibi F, Abdellaoui M, Bouhafa T, Benatiya Andaloussi I. La kératite neurotrophique secondaire à la radiothérapie des UCNT du cavum (à propos de deux cas). J Fr Ophtalmol 2022; 45:e407-e410. [DOI: 10.1016/j.jfo.2021.12.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Accepted: 12/27/2021] [Indexed: 11/29/2022]
|
7
|
Alami Z, Farhane FZ, Bouziane A, Mhirech S, Amrani Joutei S, Hassani W, Bouhafa T. Management of Esthesioneuroblastoma: A Retrospective Study of 6 Cases and Literature Review. Case Rep Oncol 2022; 15:176-186. [PMID: 35431860 PMCID: PMC8958627 DOI: 10.1159/000521736] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Accepted: 12/03/2021] [Indexed: 11/19/2022] Open
Abstract
The esthesioneuroblastoma (ENB) is a rare malignant sinonasal tumor of neuroectodermal origin. This study aimed to improve the understanding of the clinical features by reviewing the literature and analyzing the medical records of patients diagnosed with ENB in our institution between 2012 and 2019. A total of 6 cases of ENB were available for analysis. The mean age at the time of diagnosis was 36 years. The main complaints at presentation were the rhinologic signs. Tumors were classified as stage C of Kadisk in 3 cases and stage D in the others. According to TNM (modified by Dulguerov), 2 patients were T3N0M0, one T4N0M0, one T3N1M0, and two T4N1M0. The diagnosis of ENB was based on pathological examination. According to Hyams histological grading, low-grade lesions (Hyams I and II) were seen in 2 cases, high-grade undifferentiated lesions (Hyams III and IV) were seen in 4. Of the 6 patients, 4 received surgery. The surgical approaches mainly included an endoscopic endonasal resection in 2 cases, a cranial-facial resection surgery in 1 case, and an expanded endoscopic endonasal approach in combination with craniotomy in 1 case. Four patients received adjuvant radiotherapy (RT). RT dose ranged from 60 to 70 Gy. A total of 3 patients had lymph node metastasis and received RT of the neck. Chemotherapy was delivered in 2 patients. After a mean follow-up of 4.5 years, 4 patients were free of recurrence. Unfortunately, 1 patient died from a progressive disease 6 months after RT. ENB is a rare locally aggressive tumor of the nasosinusal cavities. The first-line treatment for resectable tumors should include primary surgical resection with adjuvant RT. However, this tumor remains of poor prognosis. Therefore, long-term close follow-up based on symptoms, endoscopy, and imaging is essential.
Collapse
Affiliation(s)
- Zenab Alami
- Faculty of Medicine and Pharmacy, Sidi Mohammed Ben-Abdellah University, Fes, Morocco
- Radiotherapy Department, Oncology Hospital, Hassan II University Hospital, Fes, Morocco
- Institut de Recherche sur le Cancer, Fes, Morocco
- *Zenab Alami,
| | - Fatima Zahrae Farhane
- Faculty of Medicine and Pharmacy, Sidi Mohammed Ben-Abdellah University, Fes, Morocco
- Radiotherapy Department, Oncology Hospital, Hassan II University Hospital, Fes, Morocco
- Institut de Recherche sur le Cancer, Fes, Morocco
| | - Amina Bouziane
- Faculty of Medicine and Pharmacy, Sidi Mohammed Ben-Abdellah University, Fes, Morocco
- Radiotherapy Department, Oncology Hospital, Hassan II University Hospital, Fes, Morocco
| | - Samiya Mhirech
- Faculty of Medicine and Pharmacy, Sidi Mohammed Ben-Abdellah University, Fes, Morocco
- Radiotherapy Department, Oncology Hospital, Hassan II University Hospital, Fes, Morocco
| | - Sara Amrani Joutei
- Faculty of Medicine and Pharmacy, Sidi Mohammed Ben-Abdellah University, Fes, Morocco
- Radiotherapy Department, Oncology Hospital, Hassan II University Hospital, Fes, Morocco
| | - Wissal Hassani
- Faculty of Medicine and Pharmacy, Sidi Mohammed Ben-Abdellah University, Fes, Morocco
- Radiotherapy Department, Oncology Hospital, Hassan II University Hospital, Fes, Morocco
- Institut de Recherche sur le Cancer, Fes, Morocco
| | - Touria Bouhafa
- Faculty of Medicine and Pharmacy, Sidi Mohammed Ben-Abdellah University, Fes, Morocco
- Radiotherapy Department, Oncology Hospital, Hassan II University Hospital, Fes, Morocco
- Institut de Recherche sur le Cancer, Fes, Morocco
| |
Collapse
|
8
|
Otmani IE, Effared B, Agy FE, Abkari ME, Mazaz K, Benjelloun EB, Ousadden A, Benbrahim Z, Bouhafa T, Chbani L. Lymph Nodes With Germinal Centers Are Not Associated With Tumor Response After Neoadjuvant Treatment in Locally Advanced Rectal Cancer. Clin Med�Insights�Pathol 2022; 15:2632010X221132974. [PMCID: PMC9629553 DOI: 10.1177/2632010x221132974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/26/2022] [Accepted: 09/28/2022] [Indexed: 11/06/2022]
Abstract
In patients with locally advanced rectal cancer, neoadjuvant radiotherapy or chemoradiotherapy followed by total mesorectal excision as a standard of care. We aimed to explore the number, size, germinal centers, extracapsular invasion of lymph nodes (LN), and their impact on overall survival and disease free survival. Furthermore we also investigated the characteristics of lymph nodes in patients who received neoadjuvant therapy and those who underwent surgery between 2011 and 2018. The count and measurement of lymph nodes was assessed by careful visual inspection and manual palpation. The predictive cut-off value of the lymph node ratio (LNR) was determined based on the receiver operating characteristic (ROC), method and the survival outcomes based on Kaplan-Meier curves. We found that the size and the number of lymph nodes decreased significantly after neoadjuvant treatment. The mean LN for patients who received neoadjuvant therapy was 12.68 ± 6.69 and for patients who did not receive neoadjuvant therapy was 16.29 ± 5.61 ( P = .012). The average size for patients who received neoadjuvant therapy followed by surgery was 3.30 ± 1.10 versus 4.22 ± 1.18 mm for control group (surgery only) ( P < .001), an LNR of 0.13 (sensitivity: 86%, specificity: 47%, AUC: 60%, 95% CI, 0.41%-0.76%) predicted recurrence and metastasis. Presence of lymph nodes with germinal centers was significantly associated with absence of vascular invasion, nodal tumor deposits, distant metastasis, and lower age group (<50 years). However there was no association seen between overall survival and relapse free, total number of lymph nodes enlarged and extracapsular invasion in positive nodes. Finally there is no association between lymph nodes with germinal centers and tumor response after neoadjuvant treatment in locally advanced rectal cancer.
Collapse
Affiliation(s)
- Ihsane El Otmani
- Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
- Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat, Morocco
| | - Boubacar Effared
- Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| | - Fatima El Agy
- Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
- Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| | - Mohammed El Abkari
- Department of Gastroenterology, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| | - Khalid Mazaz
- Department of General surgery, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| | - El Bachir Benjelloun
- Department of General surgery, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| | - Abdelmalek Ousadden
- Department of General surgery, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| | - Zineb Benbrahim
- Department of Medical Oncology, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| | - Touria Bouhafa
- Department of Radiotherapy, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| | - Laila Chbani
- Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
- Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed BenAbdellah, Fez, Morocco
| |
Collapse
|
9
|
Ait Erraisse M, Abboud F, Youssoufi M, Bougtib M, Bouhafa T, Hassouni K. PO-0199 HDR brachytherapy as a salvage therapy in head and neck cancers. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06358-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
10
|
Abboud FZ, Youssoufi MA, Zoukal S, Bouhafa T, Hassouni K. Recurrent pterygo-palatal angiofibroma with intracranial extension: case report. Pan Afr Med J 2020; 36:128. [PMID: 32849983 PMCID: PMC7422746 DOI: 10.11604/pamj.2020.36.128.22435] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2020] [Accepted: 06/04/2020] [Indexed: 11/30/2022] Open
Abstract
We report the case of a patient with recurrent pterygo-palatal angiofibroma and its treatment. A 21-year-old male patient had a long history of recurrent epistaxis with progressive nasal obstruction. He was diagnosed with an angiofibroma centered in the right pterygo-palatine fossa. Initially, he underwent surgical excision with removal of the entire tumor. The evolution was clinically good with no signs of recurrence on the cervico-facial scan of control (CT). Nine months after, he presented a reappearance of epistaxis. A cervico-facial MRI was performed and showed a recurrence of the tumor process, which this time was considered inextirpable, hence the decision to opt for radiotherapy with intensity modulated radiation therapy (IMRT). He has improved clinically with a clear reduction in tumor mass on CT scan. This technique represents an interesting alternative to overcome anatomical complexity of the region, cover the tumor and preserve the organs at risk.
Collapse
Affiliation(s)
- Fatima Zahra Abboud
- Department of Radiation Oncology, University Hospital Hassan II, Fez, Morocco
| | - Moulay Ali Youssoufi
- Medical Physics Unit, Oncology Hospital, University Hospital Hassan II, Fez, Morocco
| | - Sofia Zoukal
- Epidemiology Laboratory of the Faculty of Medicine and Pharmacy of Casablanca, Casablanca, Morocco
| | - Touria Bouhafa
- Department of Radiation Oncology, University Hospital Hassan II, Fez, Morocco
| | - Khalid Hassouni
- Department of Radiation Oncology, University Hospital Hassan II, Fez, Morocco
| |
Collapse
|
11
|
Abboud FZ, Youssoufi MA, Bouhafa T, Hassouni K. A solitary hemangioblastoma of the posterior brain fossa: the role of radiotherapy. Pan Afr Med J 2020; 36:114. [PMID: 32821325 PMCID: PMC7406467 DOI: 10.11604/pamj.2020.36.114.22282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2020] [Accepted: 04/30/2020] [Indexed: 11/11/2022] Open
Abstract
We report here the case of a patient admitted for management of posterior fossa cerebral hemangioblastoma. A 16-year-old male patient with a history of intracranial hypertension syndrome consisting of progressively worsening headache, vomiting, especially morning and jet vomiting, and decreased visual acuity. The patient's symptomatology worsened a few days later with the appearance of a disturbance of balance with enlargement of the sustentation polygon. The patient initially benefited from a brain computed tomography (CT) scan that objectified a solidocystic process of the posterior brain fossa. The patient then underwent a surgical excision that was considered partial and the diagnosis of hemangioblastoma was made on the surgical specimen. Since the surgical removal was partial the patient was referred to our training where he received external radiotherapy on his hemangioblastoma of the posterior brain fossa. The patient was examined one month after the end of irradiation; he presented a spectacular improvement in his neurological symptomatology with a clear regression of balance disorders. The standard treatment for cerebellar hemangioblastoma is complete microsurgical removal, but our results show a high level of efficacy for fractional photon radiotherapy after partial surgery of this benign tumour.
Collapse
Affiliation(s)
- Fatima Zahra Abboud
- Department of Radiation Oncology, University Hassan II, Hospital of Fez, Fez, Morocco
| | - Moulay Ali Youssoufi
- Medical Physics Unit, Oncology Hospital, University Hospital Hassan II, Fez, Morocco
| | - Touria Bouhafa
- Department of Radiation Oncology, University Hassan II, Hospital of Fez, Fez, Morocco
| | - Khalid Hassouni
- Department of Radiation Oncology, University Hassan II, Hospital of Fez, Fez, Morocco
| |
Collapse
|
12
|
Erraisse MA, Hassani W, Bouhafa T, Hassouni K. CONCOMITANT CHEMORADIOTHERAPY FOR UNRESECTABLE NON-METASTATIC INFLAMMATORY AND LOCALLY ADVANCED BREAST CANCER. Breast 2019. [DOI: 10.1016/s0960-9776(19)30711-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
13
|
Erraisse MA, Hassani W, Bouhafa T, Hassouni K. HYPOFRACTIONATED RADIOTHERAPY FOR INFLAMMATORY BREAST CANCER. Breast 2019. [DOI: 10.1016/s0960-9776(19)30709-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
14
|
Allouche F, Ennouichi R, Alami Z, Bouhafa T, Hassouni K. Radiothérapie du cancer de l’œsophage : expérience du service de radiothérapie du CHU Hassan-II de Fès. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
15
|
Khalfi S, Lakhmais K, Oulabbes K, Alami Z, Bouhafa T, Hassouni K. Évaluation clinique et dosimétrique des récidives locorégionales des carcinomes épidermoides de l’oropharynx. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
16
|
Abboud F, Maatallaoui M, Alami Z, Bouhafa T, Hassouni K. Place de la chimioradiothérapie concomitante dans le traitement adjuvant des adénocarcinomes gastriques : expérience du service de radiothérapie du CHU Hassan-II de Fès. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
17
|
Abboud F, Ait Erraisse M, Alami Z, Bouhafa T, Hassouni K. Curiethérapie interstitielle de haut débit de dose postopératoire exclusive des carcinomes épidermoïdes de la lèvre classés T1-2 N0N–avec résection insuffisante ou limite. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
18
|
Khalfi S, Lakhmais K, Oulabbes K, Alami Z, Bouhafa T, Hassouni K. Comparaison entre la radiothérapie externe et la curiethérapie interstitielle pour les cancers de la lèvre. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
19
|
Allouche F, Terrab F, Ennouichi R, Alami Z, Bouhafa T, Hassouni K. Comparaison des contraintes dosimétriques par les techniques de radiothérapie conformationnelle (avec modulation d’intensité ou tridimensionnelle) sur les organes à risque dans la prise en charge des tumeurs cérébrales. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
20
|
Soussy K, Ait Erraisse M, Hassani W, Youssoufi A, Alami Z, Bouhafa T, Hassouni K. Étude dosimétrique comparative entre une irradiation conformationnelle tridimensionnelle ou avec modulation d’intensité des cancers du rectum. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
21
|
Alami Z, Bouhafa T, Elmazghi A, Hassouni K. [Contribution of concomitant radiochemotherapy in the management of undifferentiated carcinoma of the nasopharynx in adults]. Pan Afr Med J 2019; 31:98. [PMID: 31019648 PMCID: PMC6465754 DOI: 10.11604/pamj.2018.31.98.14951] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2018] [Accepted: 05/09/2018] [Indexed: 11/18/2022] Open
Abstract
L'objectif de l'étude et d'Analyser les caractéristiques épidémiologiques, cliniques, thérapeutiques et évolutives du carcinome indifférencié du nasopharynx de l'adulte. Il s'agit d'une étude cohorte rétrospective portant sur 163 patients âgés de 17 ans et plus, traités pour un carcinome indifférencié du nasopharynx non métastatique. L'âge moyen des patients était de 46,5ans, avec un sexe-ratio de 1,7. 35,57% des patients étaient atteints de tumeurs localement évoluées (T3-T4) et 52,27% avec une atteinte ganglionnaire régionale avancée (N2-N3). Sur le plan thérapeutique une chimiothérapie neoadjuvante a été réalisée chez 77% des patients et 93,8% des patients ont bénéficié d'une radio-chimiothérapie concomitante. Après un recul moyen de 40,8 mois la survie globale était de 92,9% et la survie sans récidive (SSR) était de 78,9%. L'analyse de la survie sans récidive SSR en fonction des différents facteurs pronostiques a montré une différence statistiquement significative pour l'atteint ganglionnaire avec des taux de SSR à trois ans de 88%, 82,6%, 80,8% et 61,5% en cas de tumeur classée N0, N1, N2 et N3 respectivement (p = 0,02). Le cancer du nasopharynx est une maladie complexe, mais des progrès ont été accomplis grâce à des percées en radiothérapie et en biologie moléculaire. La radio-chimiothérapie concomitante représente le standard thérapeutique des stades cliniques supérieur ou égal à T2, ou supérieur ou égal à N1. Les techniques innovantes d'irradiation semblent prometteuses et pourraient pallier aux problèmes de toxicité tardive tout en assurant un excellent taux de contrôle local.
Collapse
Affiliation(s)
- Zenab Alami
- Service de Radiothérapie, CHU Hassan II, Faculté de Médecine et de Pharmacie de Fès, Maroc
| | - Touria Bouhafa
- Service de Radiothérapie, CHU Hassan II, Faculté de Médecine et de Pharmacie de Fès, Maroc
| | - Abderrahmane Elmazghi
- Service de Radiothérapie, CHU Hassan II, Faculté de Médecine et de Pharmacie de Fès, Maroc
| | - Khalid Hassouni
- Service de Radiothérapie, CHU Hassan II, Faculté de Médecine et de Pharmacie de Fès, Maroc
| |
Collapse
|
22
|
Erraisse MA, Masbah O, Bouhafa T, Hassouni K. EP-1657 Overcoming appointment delay in radiotherapy: a single institution experience. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32077-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Erraisse MA, Hassani W, Bouhafa T, Hassouni K. EP-2140 HDR Brachytherapy in Reirradiation of Local Nasopharyngeal Recurrence. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32560-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Farhane FZ, Alami Z, Bouhafa T, Elmazghi A, Hassouni K. Primary squamous cell carcinoma of endometrium: case report and literature review. Pan Afr Med J 2018; 30:208. [PMID: 30574227 PMCID: PMC6294979 DOI: 10.11604/pamj.2018.30.208.9654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Accepted: 06/14/2017] [Indexed: 11/11/2022] Open
Abstract
In this paper, we report a case of primary squamous cell carcinoma of the endometrium (PSCCE) with a literature review. A 64-year-old woman was admitted because of postmenopausal bleeding. The gynecological exam found bleeding from the endocervix. The pelvic ultrasound objectified uterine regular contours, endometrial thickened was 10 mm, the presence of an intra cavitary lesion measuring 56/70 mm. The diagnostic hysteroscopy revealed a whitish appearance taking all the uterine cavity making evoke a tumor of the endometrium. Pelvic MRI showed a tumor limited to the uterine corpus endometrium (invasion by more than 50% of the myometrium) without invasion of the cervix. Radical hysterectomy, bilateral salpingo-oophorectomy, and lymph nodes dissection were performed. Grossly, the endometrial carcinoma was polypoid tumor occupying the entire uterine cavity. Histologically, the diagnosis of SCC was retained. No adenocarcinoma element was recognized. Neither squamous metaplasia nor dysplasia was recognized. No ectopic cervical tissue was found. The SCC was found to invade into deeper one half of the myometrium. No tumor cells were seen in other sites including the cervix, ovaries, parameters, and lymph nodes. The patients was FIGO 2009 stage IB (pT1B, N0), and was treated with adjuvant radiation. The patient had a disease progression in the pelvis 3 months after the irradiation. We reported a case of PSCCE which can help to enrich the literature for the treatment and prognosis of this disease.
Collapse
Affiliation(s)
| | - Zineb Alami
- Service de Radiothérapie, CHU Hassan II Fès, Maroc
| | | | | | | |
Collapse
|
25
|
Hafidi K, Taghzout H, El Mazghi A, Bouhafa T, Hassouni K. Curiethérapie vaginale postopératoire des tumeurs de l’endomètre : à propos de 125 cas. Cancer Radiother 2018. [DOI: 10.1016/j.canrad.2018.07.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
26
|
Alami Z, Bouhafa T, Elmazghi A, Hassouni K. [Therapeutic approach against malignant Hodgkin's lymphoma during pregnancy: about a case and literature review]. Pan Afr Med J 2018; 30:20. [PMID: 30167048 PMCID: PMC6110562 DOI: 10.11604/pamj.2018.30.20.14662] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2017] [Accepted: 05/02/2018] [Indexed: 11/11/2022] Open
Abstract
Bien que le lymphome malin Hodgkinien ou (maladie de Hodgkin) ne représente que 10% de tous les lymphomes, c'est l'un des sous-types de lymphomes les plus communs diagnostiqués pendant la grossesse, en grande partie à cause de l'incidence maximale de la maladie qui coïncide avec l'âge de reproduction. La prise en charge d'une patiente enceinte atteinte d'une maladie de Hodgkin nécessite une approche multidisciplinaire, ainsi qu'une communication efficace avec le patient et sa famille. L'objectif est d'optimiser les chances de guérison de la mère tout en permettant l'accouchement d'un enfant en bonne santé. Nous rapportant un cas rare d'une patiente enceinte diagnostiquée pour une maladie de Hodgkin à 17 semaines d'aménorrhée.
Collapse
Affiliation(s)
- Zenab Alami
- Service de Radiothérapie et Curiethérapie, CHU Hassan II, Faculté de Médecine et de Pharmacie de Fès, Maroc
| | - Touria Bouhafa
- Service de Radiothérapie et Curiethérapie, CHU Hassan II, Faculté de Médecine et de Pharmacie de Fès, Maroc
| | - Abderrahmane Elmazghi
- Service de Radiothérapie et Curiethérapie, CHU Hassan II, Faculté de Médecine et de Pharmacie de Fès, Maroc
| | - Khalid Hassouni
- Service de Radiothérapie et Curiethérapie, CHU Hassan II, Faculté de Médecine et de Pharmacie de Fès, Maroc
| |
Collapse
|
27
|
Bouayad N, Oubelkacem N, Bono W, Masbah O, Bouhafa T, Elmazghi A, Khalid H. [Nasal NK/T-cell lymphoma: about two rare cases]. Pan Afr Med J 2018; 30:141. [PMID: 30374387 PMCID: PMC6201606 DOI: 10.11604/pamj.2018.30.141.7721] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2015] [Accepted: 09/01/2015] [Indexed: 11/11/2022] Open
Abstract
Le lymphome T/NK est une affection grave et rare en Afrique et en Europe. Le traitement repose sur la radiothérapie et la chimiothérapie. Les auteurs rapportent deux observations de patients âgés respectivement de 55 et 52 ans, qui présentent une obstruction nasale bilatérale avec une rhinorrhée purulente, chez eux l'examen clinique a mis en évidence la présence d'une fente palatine. Le diagnostic n'a pu être posé qu'après une étude immuno-histochimique des biopsies. Les 2 patients ont bénéficié d'une chimiothérapie type CHOEP suivi d'une cure de radiothérapie. Le lymphome T/NK nasal est une forme agressive de lymphome non hodgkinien comportant des caractéristiques clinicopathologiques qui lui sont spécifiques. L'association de la chimiothérapie pour les stades avancés ne semble pas améliorer la survie par rapport à la radiothérapie seule qui reste le traitement de choix surtout pour les stades localisés. La localisation nasal du lymphome T /NK est rare. Le diagnostic repose sur l'étude immunohistochimique. Le traitement comprend chimiothérapie et radiothérapie. Ce type lymphome est de mauvais pronostic globalement, y compris sous traitement.
Collapse
Affiliation(s)
| | | | - Wafaa Bono
- Service de Médecine Interne, CHU Hassan II-Fès, Maroc
| | | | | | | | | |
Collapse
|
28
|
Farhane FZ, Alami Z, Bouhafa T, Elmazghi A, Hassouni K. Primary squamous cell carcinoma of endometrium: case report and literature review. Pan Afr Med J 2018; 30:8. [PMID: 30123411 PMCID: PMC6093596 DOI: 10.11604/pamj.2018.30.8.8983] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2016] [Accepted: 03/01/2018] [Indexed: 11/16/2022] Open
Abstract
In this paper, we report a case of primary squamous cell carcinoma of the endometrium (PSCCE) with a literature review. A 64-year-old woman, was admitted because postmenopausal bleeding. The gynecological exam found bleeding from the endocervix. The pelvic ultrasound objectified uterine regular contours, endometrial thickened was 10 mm, the presence of an intra cavitary lesion mesuring 56/70 mm. The diagnostic hysteroscopy revealed a whitish appearance taking all the uterine cavity making evoke a tumor of the endometrium. Pelvic MRI showed a tumor limited to the uterine corpus endometrium (invasion by more than 50% of the myometrium) without invasion of the cervix. Radical hysterectomy, bilateral salpingo-oophorectomy, and lymph nodes dissection were performed. Grossly, the endometrial carcinoma was polypoid tumor occupying the entire uterine cavity. Histologically, the diagnosis of SCC was retained. No adenocarcinoma element was recognized. Neither squamous metaplasia nor dysplasia was recognized. No ectopic cervical tissue was found. The SCC was found to invade into deeper one half of the myometrium. No tumor cells were seen in other sites including the cervix, ovaries, parametres, and lymph nodes. The patients was FIGO 2009 stage IB (pT1B, N0), and was treated with adjuvant radiation. The patient had a disease progression in the pelvis 3 months after the irradiation. We reported a case of PSCCE which can help to enrich the literature for the treatment and prognosis of this disease
Collapse
Affiliation(s)
| | - Zineb Alami
- Service de Radiothérapie, CHU Hassan II Fès, Maroc
| | | | | | | |
Collapse
|
29
|
Taghzout H, Hafidi K, Alami Z, Elmazghi A, Bouhafa T, Hassouni K. Cancer du cavum chez l’adulte (à propos de 391 cas) : aspects épidémiologiques, cliniques et thérapeutiques. Cancer Radiother 2017. [DOI: 10.1016/j.canrad.2017.08.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
30
|
Farhane FZ, Alami Z, Bouhafa T, Elmazghi A, Hassouni K. Paravertebral extraskeletal myxoid chondrosarcoma: a case report and review of the literature. Pan Afr Med J 2015; 21:213. [PMID: 26448808 PMCID: PMC4587080 DOI: 10.11604/pamj.2015.21.213.6639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2015] [Accepted: 04/10/2015] [Indexed: 11/26/2022] Open
Abstract
The extraskeletal myxoid chondrosarcoma (CME) is a rare malignant soft tissue tumour described as a distinct clinical, histological, immunohistochemical, genetical and evolutive entity. It represents only 2.5% of soft tissue sarcomas. Its individualization is important because it has a long and indolent clinical course, and tumour-related death often occurs after a long survival period. The diagnostic key is morphological supported by immunohistochemistry and genetics t (9; 22) that allow differentiating it from other tumours with myxoid stroma and from chordoma. This report describes a patient with paravertebral extraskeletal myxoid chondrosrcoma with a high locoregional extension.
Collapse
Affiliation(s)
| | - Zineb Alami
- Department of Radiotherapy, Hassan II University Hospital, Fez, Morocco
| | - Touria Bouhafa
- Department of Radiotherapy, Hassan II University Hospital, Fez, Morocco
| | | | - Khalid Hassouni
- Department of Radiotherapy, Hassan II University Hospital, Fez, Morocco
| |
Collapse
|
31
|
Mazouz A, Amaadour L, souaf I, El Fatemi H, Amarti A, Erraisse MA, Oubelkacem E, Bouhafa T, Tahiri Y, Tazi MF, Mellas S, Arifi S, Mellas N. Synchronous malignant renal mass in patient with a Lung cancer: case report and literature review. Pan Afr Med J 2015; 20:22. [PMID: 26015842 PMCID: PMC4432812 DOI: 10.11604/pamj.2015.20.22.5541] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2014] [Accepted: 12/12/2014] [Indexed: 11/16/2022] Open
Abstract
The finding on imaging (computed tomography scan or magnetic resonance imaging) of synchronous malignant renal mass in patient with an active nonrenal malignancy without renal specific symptoms is not frequent and diagnostic evaluation can be challenging. We describe a 54-year-old Moroccan male former chronic smoker who presented to our hospital with dry cough and impairment of the performance status. The imaging found a tumor mass in the left upper lobe of the lung associated to mediastinal lymph node and a scanno-guided biopsy of this tumor showed a non small cell lung cancer. The radiological staging revealed a solitary renal mass in the right kidney. The patient received firstly two cycles of a lung cancer chemotherapy with a partial response in the lung and a stability of the renal mass. Consequently, he underwent a scanno-guided biopsy of this mass which confirmed a synchronous clear cell renal carcinoma. The patient got chemo radiotherapy for the lung cancer and then after that he got a partial nephrectomy. He is still under a good control with more than 2 years after the initial diagnosis.
Collapse
Affiliation(s)
- Aicha Mazouz
- Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco
| | - Lamiae Amaadour
- Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco
| | - Ihsane souaf
- Department of Pathology, Hassan II University Hospital, Fez, Morocco
| | - Hinde El Fatemi
- Department of Pathology, Hassan II University Hospital, Fez, Morocco
| | - Afaf Amarti
- Department of Pathology, Hassan II University Hospital, Fez, Morocco
| | | | | | - Touria Bouhafa
- Department of Radiotherapy, Hassan II University Hospital, Fez, Morocco
| | - Yassir Tahiri
- Department of Urology, Hassan II University Hospital, Fez, Morocco
| | | | - Soufiane Mellas
- Department of Urology, Hassan II University Hospital, Fez, Morocco
| | - Samia Arifi
- Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco
| | - Nawfel Mellas
- Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco
| |
Collapse
|
32
|
Alami Z, Bouhafa T, Farhane F, Elmazghi A, Hassouni K. [Gliosarcoma: rare tumor of the central nervous system--presentation of two cases]. Pan Afr Med J 2015; 22:305. [PMID: 26966501 PMCID: PMC4769059 DOI: 10.11604/pamj.2015.22.305.7852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2015] [Accepted: 11/14/2015] [Indexed: 11/26/2022] Open
Abstract
Le gliosarcome est une tumeur primitive mixte du système nerveux central, caractérisée par une prolifération biphasique associant un contingent glial de type glioblastome et un contingent sarcomateux. L’âge moyen de survenue de cette tumeur varie de 40 à 60 ans, avec un sex-ratio homme/femme de 1,8/1. Nous rapportons ici deux cas de gliosarcome traités dans notre service Le traitement standard consiste en une résection chirurgicale de la tumeur suivie d'une radiothérapie externe et parfois d'une chimiothérapie.
Collapse
Affiliation(s)
- Zenab Alami
- Service de Radiothérapie-Curiethérapie, CHU Hasssan II, Fes, Maroc
| | - Touria Bouhafa
- Service de Radiothérapie-Curiethérapie, CHU Hasssan II, Fes, Maroc
| | | | | | - Khalid Hassouni
- Service de Radiothérapie-Curiethérapie, CHU Hasssan II, Fes, Maroc
| |
Collapse
|
33
|
El Mazghi A, Loukili K, Mesnaoui A, Lalya I, Bouhafa T, El Kacemi H, Kebdani T, Hassouni K. [Bilateral primitive non-Hodgkin Lymphoma of the breast: about a case]. Pan Afr Med J 2015; 20:234. [PMID: 27386030 PMCID: PMC4919680 DOI: 10.11604/pamj.2015.20.234.6288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Accepted: 02/21/2015] [Indexed: 11/23/2022] Open
Abstract
Les lymphomes malins non-hodgkiniens (LMNH) primitifs du sein sont des tumeurs rares. Leur symptomatologie clinique est polymorphe. L'imagerie médicale est non-spécifique. Le diagnostic peut être évoqué à l'examen cytologique, sa confirmation est toujours histologique. Il s'agit essentiellement de lymphomes de type B, ceux de type NK/T restant rares. Les plus fréquents sont les lymphomes diffus à grandes cellules présentant la particularité de donner des rechutes sous forme d'extension au système nerveux central. Nous rapportons un cas de LMNH primitif bilatéral du sein chez une patiente âgée de 33 ans, révélé par deux nodules mammaires bilatéraux. La mammographie et l'examen extemporané ont évoqué une tumeur phyllode. Le diagnostic du LMNH n'a été fait qu'après examen histologique définitif. Sous chimiothérapie, l’évolution était favorable avec un recul de 15 mois.
Collapse
Affiliation(s)
- Abderrahman El Mazghi
- Faculté de Médecine et de Pharmacie, Université sidi Mohamed Ben Abdellah & Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| | - Kaoutar Loukili
- Faculté de Médecine et de Pharmacie, Université sidi Mohamed Ben Abdellah & Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| | - Ayoub Mesnaoui
- Faculté de Médecine et de Pharmacie, Université sidi Mohamed Ben Abdellah & Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| | - Issam Lalya
- Service de Radiothérapie, HIM Mohamed V, Rabat, Maroc
| | - Touria Bouhafa
- Faculté de Médecine et de Pharmacie, Université sidi Mohamed Ben Abdellah & Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| | - Hanan El Kacemi
- Service de Radiothérapie, Institut National d'Oncologie, Rabat, Maroc
| | - Taieb Kebdani
- Service de Radiothérapie, Institut National d'Oncologie, Rabat, Maroc
| | - Khalid Hassouni
- Faculté de Médecine et de Pharmacie, Université sidi Mohamed Ben Abdellah & Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| |
Collapse
|
34
|
Bouhafa T, Kanab R, Bouayed N, Masbah O, Elmazghi A, Mellas N, Hassouni K. Carcinome neuroendocrine à petites cellules de la vulve. ACTA ACUST UNITED AC 2014; 42:877-9. [DOI: 10.1016/j.gyobfe.2014.07.032] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2013] [Accepted: 02/11/2014] [Indexed: 11/28/2022]
|
35
|
El mazghi A, Bouhafa T, Loukili K, El kacemi H, Lalya I, Kebdani T, Hassouni K. [Intracystic papillary carcinoma of the breast: report of three cases]. Pan Afr Med J 2014; 18:207. [PMID: 25419333 PMCID: PMC4237595 DOI: 10.11604/pamj.2014.18.207.4519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2014] [Accepted: 05/19/2014] [Indexed: 11/17/2022] Open
Abstract
Le Carcinome papillaire intra-kystique du sein est une entité très rare et représente 0,5 à 1% de l'ensemble des carcinomes mammaires. Il se caractérise généralement par une croissance lente avec un bon pronostic. Nous rapportons 03 nouveaux cas prouvés histologiquement, chez des patientes traitées par chirurgie radicale ou conservatrice, suivie d'une radiothérapie sur le sein en place et une hormonothérapie à base de tamoxifen chez les deux patientes avec des récepteurs hormonaux positifs. Les trois patientes sont en bon contrôle locorégionale avec des suivis post-thérapeutiques de 12 à 18 mois.
Collapse
Affiliation(s)
| | | | | | - Hanan El kacemi
- Service de Radiothérapie, Institut National d'Oncologie, Rabat, Maroc
| | - Issam Lalya
- Service de Radiothérapie, HIM Mohamed V, Rabat, Maroc
| | - Taieb Kebdani
- Service de Radiothérapie, Institut National d'Oncologie, Rabat, Maroc
| | | |
Collapse
|
36
|
El Mazghi A, Bouhafa T, El Kacemi H, Loukili K, Chbani L, Kebdani T, Hassouni K. [Role of radiotherapy in the treatment of ameloblastoma: report of two cases]. Pan Afr Med J 2014; 19:89. [PMID: 25722762 PMCID: PMC4335278 DOI: 10.11604/pamj.2014.19.89.4491] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2014] [Accepted: 09/12/2014] [Indexed: 11/23/2022] Open
Abstract
L'améloblastome est une tumeur odontogène bénigne mais à pouvoir agressif et invasif local important. C'est une tumeur rare, elle représente 1% des tumeurs des maxillaires. Le rôle de la radiothérapie dans son traitement est actuellement démontré pour les tumeurs inopérables. Nous rapportons 2 cas d'améloblastomes mandibulaires chez deux patients qui ont bénéficié d'une radiothérapie externe à la dose de 60 Gy. L’évolution a été marquée par une rémission complète de la maladie dans les deux cas avec un recul de 2 et 5 ans.
Collapse
Affiliation(s)
| | | | - Hanan El Kacemi
- Service de Radiothérapie, Institut national d'Oncologie, Rabat, Maroc
| | | | - Laila Chbani
- Service d'Anatomie Pathologique, CHU Hassan II, Fès, Maroc
| | - Taieb Kebdani
- Service de Radiothérapie, Institut national d'Oncologie, Rabat, Maroc
| | | |
Collapse
|
37
|
Jayi S, Bouguern H, Fdili FZ, Chaara H, Chbani L, Hafidi I, Kamaoui I, Arifi S, Mellas N, Bouhafa T, Hassouni K, Tizniti S, Laamarti A, Melhouf MA. Embryonal rhabdomyosarcoma of the cervix presenting as a cervical polyp in a 16-year-old adolescent: a case report. J Med Case Rep 2014; 8:241. [PMID: 24986146 PMCID: PMC4092352 DOI: 10.1186/1752-1947-8-241] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2013] [Accepted: 04/07/2014] [Indexed: 11/10/2022] Open
Abstract
INTRODUCTION Embryonal rhabdomyosarcoma of the female genital tract is rare in the cervix. It has been mainly discussed in the context of individual case studies. It tends to occur in children and young women. Treatment ranges from radical surgery to conservative surgery, followed by chemotherapy. CASE PRESENTATION A 16-year-old Moroccan adolescent girl presented to our center with a protruding mass from her vaginal introitus, as a polyp of 6cm. An examination revealed a polyp within her vagina, thought to be arising from her cervix and a polypectomy was performed. Microscopic findings are consistent with an embryonal rhabdomyosarcoma (botryoide type). A computed tomography of her thorax, abdomen and pelvis were performed and residual disease was found as a mass located at her cervix, which measured approximately 4.5cm in its widest dimensions, without evidence of metastatic disease. Due to the fact that she is young, after discussions in a multidisciplinary meeting, she was subsequently treated with four cycles of multi-agent chemotherapy. Two cycles of chemotherapy and radiotherapy were administered due to the lack of response, but she presented vaginal bleeding with persistence of the same mass in computed tomography. Hence a total interadnexal hysterectomy was made. A histologic examination found residual embryonal rhabdomyosarcoma (botryoide type) located in all her cervix and she is currently under chemotherapy. CONCLUSIONS The presence of a cervical polyp in an adolescent is a gynecologic oddity and must necessarily be examined histologically because it might be a rhabdomyosarcoma. This is extremely important because diagnosis at an early stage of the disease is a highly favorable prognostic factor that allows "fertility-sparing surgery" for these young patients.
Collapse
Affiliation(s)
- Sofia Jayi
- Department of Gynecology and Obstetrics, University Hospital of Fez, Fez, Morocco.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Abstract
La compression médullaire d'origine métastatique est une complication neurologique fréquente du cancer. C'est une urgence diagnostique et thérapeutique qui nécessite une prise en charge rapide et efficace. L'imagerie par résonnance magnétique (IRM) constitue l'examen de choix pour l'exploration de l'ensemble de la moelle. La prise en charge thérapeutique doit être multidisciplinaire incluant la corticothérapie, la radiothérapie et la chirurgie.
Collapse
Affiliation(s)
- Touria Bouhafa
- Service de Radiothérapie, CHU Hassan II de FES, Faculté de Médecine et de Pharmacie de Fès, Fès, Maroc
| | - Abderrahman Elmazghi
- Service de Radiothérapie, CHU Hassan II de FES, Faculté de Médecine et de Pharmacie de Fès, Fès, Maroc
| | - Ouafae Masbah
- Service de Radiothérapie, CHU Hassan II de FES, Faculté de Médecine et de Pharmacie de Fès, Fès, Maroc
| | - Khalid Hassouni
- Service de Radiothérapie, CHU Hassan II de FES, Faculté de Médecine et de Pharmacie de Fès, Fès, Maroc
| |
Collapse
|
39
|
El Mazghi A, Bouhafa T, Loukili K, El Kacemi H, Lalya I, Hassouni K. [Management of cervical cancer during pregnancy: report of 05 cases]. Pan Afr Med J 2014; 19:245. [PMID: 25852788 PMCID: PMC4382065 DOI: 10.11604/pamj.2014.19.245.5094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2014] [Accepted: 09/27/2014] [Indexed: 11/24/2022] Open
Abstract
L'association d'un cancer du col utérin avec une grossesse est une éventualité rare. Son incidence est assez mal évaluée, elle se situe selon les études entre 1 et 2/10 000. Lorsque la découverte en est faite, il faut conjuguer deux impératifs parfois totalement divergents: le traitement de la mère et la prise en charge du foetus. Cette association pose schématiquement quatre grands problèmes, qui sont: Celui du diagnostic, qui est loin d’être évident, compte tenu des remaniements cervicaux observés en début de gestation, le pronostic de l'affection, la date du traitement chirurgical et du délai entre le diagnostic et la prise en charge thérapeutique, enfin et de manière plus accessoire, le devenir de la grossesse et le mode d'accouchement. Nous rapportons une série de 5 cas de cancer du col utérin découverts au cours de la grossesse colligés dans notre service entre 2010 et 2013. La prise en charge thérapeutique est identique à celle des patientes en dehors de la grossesse même si quelques adaptations sont nécessaires du fait de l’état gravide, le pronostic du cancer ne semble pas être modifié par la grossesse.
Collapse
Affiliation(s)
- Abderrahman El Mazghi
- Faculté de Médecine, Université Sidi Mohamed Ben Abdallah, Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| | - Touria Bouhafa
- Faculté de Médecine, Université Sidi Mohamed Ben Abdallah, Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| | - Kaoutar Loukili
- Faculté de Médecine, Université Sidi Mohamed Ben Abdallah, Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| | - Hanan El Kacemi
- Service de Radiothérapie, Institut National d'Oncologie, Rabat, Maroc
| | - Issam Lalya
- Service de Radiothérapie, HIM Mohamed V, Rabat, Maroc
| | - Khalid Hassouni
- Faculté de Médecine, Université Sidi Mohamed Ben Abdallah, Service de Radiothérapie, CHU Hassan II, Fès, Maroc
| |
Collapse
|
40
|
Alami Z, Farhane F, Loukili K, Bouayad N, Mesbah O, Elmazghi A, Bouhafa T, Hassouni K. Prise en charge du carcinome épidermoïde du col utérin dans le service de radiothérapie du centre hospitalier universitaire Hassan-II de Fès (à propos de 160 cas). Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
Iraqi M, Kebdani T, Bouhafa T, Zaghba N, Bendouro H, Bekkouch I, El Hassouni K, El Mansouri A, Benjaafar N, El Gueddari B. Rôle de la radiothérapie dans le traitement des améloblastomes. Cancer Radiother 2008. [DOI: 10.1016/j.canrad.2008.08.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
42
|
Bekkouch I, Kebdani T, Masbah O, Bouhafa T, Zaghba N, Hassouni K, Elkacemi H, Mansouri A, Benjaafar N, El Gueddari B. Le sarcome de Kaposi : à propos de 32 cas. Cancer Radiother 2008. [DOI: 10.1016/j.canrad.2008.08.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
43
|
Harandou M, Khatouf M, Bouhafa T, Kanjaa N, Leclercq G, Lapostolle F. Une pyélonéphrite emphysémateuse d'évolution favorable après traitement conservateur. ACTA ACUST UNITED AC 2005; 24:556-8. [PMID: 15904737 DOI: 10.1016/j.annfar.2005.01.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2004] [Accepted: 01/18/2005] [Indexed: 11/19/2022]
Abstract
Emphysematous pyelonephritis is a necrotizing renal infection characterized by bacterial gas production in the renal and perirenal area. It is a rare infection diagnosed in diabetic patients in most cases. Emphysematous pyelonephritis is responsible for a high mortality rate. We report the case of a woman, unknown diabetic, who presented with emphysematous pyelonephritis. Early diagnosis performed by CT-scan allowed effective and conservative surgical treatment and final positive outcome.
Collapse
Affiliation(s)
- M Harandou
- Service de réanimation chirurgicale, hôpital Al-Ghassani, Fès, Morocco
| | | | | | | | | | | |
Collapse
|